Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Scalp edema may be a new variant of conditions reacting to scarring alopecia like LPP.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.